JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
|
+$1.58B |
| 2 |
Vanguard FTSE Europe ETF
VGK
|
+$1B |
| 3 |
CPGX
COLUMBIA PIPELINE GROUP IN COM STK (DE)
CPGX
|
+$958M |
| 4 |
Eli Lilly
LLY
|
+$776M |
| 5 |
AGN
Allergan plc
AGN
|
+$751M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.23B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.98B |
| 3 |
Johnson & Johnson
JNJ
|
+$1.31B |
| 4 |
Merck
MRK
|
+$837M |
| 5 |
Bread Financial
BFH
|
+$630M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.59% |
| 2 | Financials | 15.13% |
| 3 | Healthcare | 11.59% |
| 4 | Technology | 11.09% |
| 5 | Consumer Discretionary | 8.78% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
NSL
2201
DELISTED
NUVEEN SENIOR INCM FD
NSL
| $4.28M | ﹤0.01% |
723,322
| – | – |
2013 Q2
9 quarters
|
|
2202
BlackRock Corporate High Yield Fund
HYT
$1.53B
| $4.27M | ﹤0.01% |
+432,600
| New | +$4.46M |
2015 Q3
0 quarters
|
|
2203
First Financial Bankshares
FFIN
$4.55B
| $4.27M | ﹤0.01% |
268,658
+1,798
| +0.7% | +$29.2K |
2013 Q2
9 quarters
|
|
2204
State Street Global Allocation ETF
GAL
$314M
| $4.26M | ﹤0.01% |
131,003
+19,002
| +17% | +$647K |
2015 Q1
2 quarters
|
|
2205
Addus HomeCare
ADUS
$2.09B
| $4.25M | ﹤0.01% |
+136,405
| New | +$3.99M |
2015 Q3
0 quarters
|
|
2206
PUT
Pultegroup
PHM
$22.2B
| $4.25M | ﹤0.01% |
225,000
| – | – |
2014 Q3
4 quarters
|
|
2207
PUT
Ralph Lauren
RL
$21.6B
| $4.24M | ﹤0.01% |
35,900
| – | – |
2015 Q1
2 quarters
|
|
|
CBPX
2208
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $4.24M | ﹤0.01% |
+206,388
| New | +$4.33M |
2015 Q3
0 quarters
|
|
2209
First Merchants
FRME
$2.49B
| $4.22M | ﹤0.01% |
161,010
+2,000
| +1% | +$51.7K |
2013 Q2
9 quarters
|
|
2210
CALL
Public Service Enterprise Group
PEG
$33.8B
| $4.22M | ﹤0.01% |
100,000
| – | – |
2015 Q2
1 quarter
|
|
2211
Heron Therapeutics
HRTX
$67.6M
| $4.21M | ﹤0.01% |
+172,689
| New | +$5.76M |
2015 Q3
0 quarters
|
|
|
JRO
2212
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
| $4.21M | ﹤0.01% |
423,000
-24,000
| -5% | -$253K |
2013 Q2
9 quarters
|
|
2213
PUT
Blackstone
BX
$84.3B
| $4.2M | ﹤0.01% |
135,018
+38,519
| +40% | +$1.39M |
2014 Q3
4 quarters
|
|
2214
Methode Electronics
MEI
$509M
| $4.19M | ﹤0.01% |
131,378
-23,274
| -15% | -$656K |
2013 Q2
9 quarters
|
|
2215
Encore Capital Group
ECPG
$2B
| $4.17M | ﹤0.01% |
112,639
+1,980
| +2% | +$80.9K |
2013 Q2
9 quarters
|
|
2216
Metallus
MTUS
$805M
| $4.16M | ﹤0.01% |
411,311
-104,865
| -20% | -$1.9M |
2014 Q3
4 quarters
|
|
|
BMS
2217
DELISTED
Bemis
BMS
| $4.15M | ﹤0.01% |
104,849
-45,338
| -30% | -$1.99M |
2013 Q2
9 quarters
|
|
2218
Werner Enterprises
WERN
$2.06B
| $4.15M | ﹤0.01% |
165,202
-99,475
| -38% | -$2.72M |
2014 Q4
3 quarters
|
|
|
ODP
2219
PUT
DELISTED
ODP
ODP
| $4.13M | ﹤0.01% |
64,400
+37,000
| +135% | +$2.88M |
2014 Q3
4 quarters
|
|
2220
PUT
Abercrombie & Fitch
ANF
$5.79B
| $4.13M | ﹤0.01% |
195,000
| – | – |
2014 Q3
4 quarters
|
|
|
BFS
2221
Saul Centers
BFS
$741M
| $4.12M | ﹤0.01% |
79,674
+7,155
| +10% | +$365K |
2013 Q2
9 quarters
|
|
|
PRTK
2222
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $4.12M | ﹤0.01% |
217,017
+115
| +0.1% | +$2.87K |
2015 Q1
2 quarters
|
|
2223
Resources Connection
RGP
$132M
| $4.11M | ﹤0.01% |
272,534
-49,216
| -15% | -$780K |
2013 Q2
9 quarters
|
|
2224
Assured Guaranty
AGO
$3B
| $4.11M | ﹤0.01% |
164,226
-278,918
| -63% | -$7.02M |
2013 Q2
9 quarters
|
|
2225
Watts Water Technologies
WTS
$12B
| $4.11M | ﹤0.01% |
77,723
-11,800
| -13% | -$627K |
2013 Q2
9 quarters
|
|
Similar funds
JP Morgan Chase's Q3 2015 Portfolio in Review
As of Q3 2015, JP Morgan Chase held 4,367 positions worth $374B, down 12% from $424B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase withdrew a net $18B in Q3 2015, closing 488 positions and reducing 1,582 holdings. Its most notable exit was ROCK-TENN COMPANY CL-A, an estimated $559M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
Against the trend, JP Morgan Chase opened a new position in COLUMBIA PIPELINE GROUP IN COM STK (DE) worth $672M.
- JP Morgan Chase's largest Q3 2015 buy was COLUMBIA PIPELINE GROUP IN COM STK (DE): 36,762,567 shares worth $672M.
- JP Morgan Chase added most to Xtrackers MSCI EAFE Hedged Equity ETF in Q3 2015, an estimated $1.58B increase.
- JP Morgan Chase's biggest Q3 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.23B.
- JP Morgan Chase fully exited ROCK-TENN COMPANY CL-A in Q3 2015, selling an estimated $559M.
- JP Morgan Chase's ten largest holdings make up 17% of its $374B portfolio in Q3 2015.
- JP Morgan Chase opened 374 new positions and closed 488 in Q3 2015.
- JP Morgan Chase's portfolio value fell 12% quarter-over-quarter to $374B.
Based on JP Morgan Chase's 13F filing for Q3 2015, filed 13 Nov 2015.